217
Views
18
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy

, , , , , , , & show all
Pages 267-275 | Received 24 Dec 2014, Accepted 02 Mar 2015, Published online: 07 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Angela Lopomo & Fabio Coppedè. (2018) Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers. Expert Review of Gastroenterology & Hepatology 12:1, pages 49-62.
Read now

Articles from other publishers (17)

Wiktoria Maria Izdebska, Jaroslaw Daniluk & Jacek Niklinski. (2023) Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma. Journal of Clinical Medicine 12:17, pages 5643.
Crossref
Sharmila Rana, Gabriel N. Valbuena, Ed Curry, Charlotte L. Bevan & Hector C. Keun. (2022) MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data. British Journal of Cancer 126:3, pages 502-513.
Crossref
Mohammad Reza Karimzadeh, Peyman Pourdavoud, Naeim Ehtesham, Mohaddese Qadbeigi, Masood Movahedi Asl, Behrang Alani, Meysam Mosallaei & Bahram Pakzad. (2020) Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy. Cancer Gene Therapy 28:3-4, pages 157-174.
Crossref
Julia Paczkowska, Joanna Janiszewska, Julia Bein, Markus Schneider, Kinga Bednarek, Adam Ustaszewski, Sylvia Hartmann, Martin-Leo Hansmann & Maciej Giefing. (2020) The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma. Cells 9:10, pages 2292.
Crossref
Kah Keng Wong. (2020) DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications. Cellular Oncology 43:5, pages 779-792.
Crossref
Ziyi Li, Weidong Li, Yuqi Dong & Xueying Sun. (2019) Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer. Clinical Cancer Drugs 6:1, pages 8-20.
Crossref
Xiao‑Xue Wang, Heyang Zhang & Yan Li. (2019) Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia. Molecular Medicine Reports.
Crossref
Sameer Dhayat, Max Traeger, Jan Rehkaemper, Anda Stroese, Konrad Steinestel, Eva Wardelmann, Iyad Kabar & Norbert Senninger. (2018) Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma. Cancers 10:9, pages 328.
Crossref
Christiane Matuszcak, Kirsten Lindner, Ann-Kathrin Eichelmann, Damian J. Hussey, Jörg Haier & Richard Hummel. (2018) microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma. Surgical Oncology 27:3, pages 392-401.
Crossref
Edita Baltruskeviciene, Diana Schveigert, Vaidotas Stankevicius, Ugnius Mickys, Tadas Zvirblis, Jaroslav Bublevic, Kestutis Suziedelis & Eduardas Aleknavicius. (2017) Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding. BMC Cancer 17:1.
Crossref
Ping Wang, Xiangping Li, Lihua Cao, Shihai Huang, Haiyan Li, Yan Zhang, Ting Yang, Jianrong Jiang & Deshun Shi. (2017) MicroRNA-148a overexpression improves the early development of porcine somatic cell nuclear transfer embryos. PLOS ONE 12:6, pages e0180535.
Crossref
Long Peng, Zhanying Liu, Jian Xiao, Yi Tu, Zhen Wan, Haiwei Xiong, Yong Li & Weidong Xiao. (2017) MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway. Oncology Reports.
Crossref
Keiichi Yonemori, Naohiko Seki, Hiroshi Kurahara, Yusaku Osako, Tetsuya Idichi, Takayuki Arai, Keiichi Koshizuka, Yoshiaki Kita, Kosei Maemura & Shoji Natsugoe. (2017) ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma . Cancer Science 108:1, pages 124-135.
Crossref
Keiichi Yonemori, Hiroshi Kurahara, Kosei Maemura & Shoji Natsugoe. (2016) MicroRNA in pancreatic cancer. Journal of Human Genetics 62:1, pages 33-40.
Crossref
Xiao Wang, Zhen Liang, Xin Xu, Jiangfeng Li, Yi Zhu, Shuai Meng, Shiqi Li, Song Wang, Bo Xie, Alin Ji, Ben Liu, Xiangyi Zheng & Liping Xie. (2016) miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer. Cell Death & Disease 7:12, pages e2503-e2503.
Crossref
Marta Passadouro & Henrique Faneca. (2016) Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy. International Journal of Molecular Sciences 17:5, pages 718.
Crossref
Zeynep F. Karagonlar, Peyda Korhan & Neşe Atabey. (2015) Targeting c‐ M et in Cancer by Micro RNA s: Potential Therapeutic Applications in Hepatocellular Carcinoma . Drug Development Research 76:7, pages 357-367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.